PIGR and cancer: Evidence also suggests that decreased PIGR expression correlates with tumor progression and poor prognosis in several cancers, including nasopharyngeal carcinoma, esophageal squamous cell carcinoma, gastric adenocarcinoma, lung cancer, and epithelial ovarian cancer (18–22).